BACKGROUND: HIV-infected patients with pulmonary tuberculosis exhibit atypical radiological presentation and negative sputum smear more frequently than their HIV-negative counterparts. PATIENTS AND METHODS: We performed a retrospective study based on a chart review of 146 HIV-infected patients with pulmonary symptoms and culture-proven pulmonary tuberculosis. We compared clinical characteristics and the outcome in 71 patients (49%) with positive sputum smear (SS+), 62 patients (42%) with negative sputum smear/abnormal chest X-ray (SS-/CXR+) and 13 patients (9%) with negative sputum smear/normal chest X-ray (SS-/CXR-). Patients were enrolled from January 1987 to December 1998, and were followed up until December 1999. RESULTS: On hospital admission the three groups of patients examined did not differ significantly in demographic characteristics, degree of immunosuppression or Mycobacterium tuberculosis drug-susceptibility pattern. SS-/CXR- patients were significantly Less LikeLy to present with prolonged fever and dyspnea. Median survival was shorter for SS-/CXR- patients (6.4 months vs 20.2 and 18.8 months in the other two groups). In multivariate analysis, SS-/CXR-patients had a significantly increased risk of death (hazard ratio 3.0, 95% confidence interval, 1.4 to 6.4, p = 0.004) compared to SS+ patients. This increase in risk was no longer statistically significant when initiation of antituberculous therapy within 8 weeks from the collection date of the first specimen yielding M. tuberculosis was included in the multivariate model. CONCLUSION: Decreased survival was observed in HIV-infected patients with pulmonary tuberculosis and with both negative sputum smear and normaL chest X-ray presentation. This may primarily be a resuLt of delayed tuberculosis diagnosis and initiation of antituberculous therapy. The latter delay may also lead to a faster progression of HIV infection in SS-/CXR patients, in whom diagnostic oversight may be common.
BACKGROUND:HIV-infectedpatients with pulmonary tuberculosis exhibit atypical radiological presentation and negative sputum smear more frequently than their HIV-negative counterparts. PATIENTS AND METHODS: We performed a retrospective study based on a chart review of 146 HIV-infectedpatients with pulmonary symptoms and culture-proven pulmonary tuberculosis. We compared clinical characteristics and the outcome in 71 patients (49%) with positive sputum smear (SS+), 62 patients (42%) with negative sputum smear/abnormal chest X-ray (SS-/CXR+) and 13 patients (9%) with negative sputum smear/normal chest X-ray (SS-/CXR-). Patients were enrolled from January 1987 to December 1998, and were followed up until December 1999. RESULTS: On hospital admission the three groups of patients examined did not differ significantly in demographic characteristics, degree of immunosuppression or Mycobacterium tuberculosis drug-susceptibility pattern. SS-/CXR- patients were significantly Less LikeLy to present with prolonged fever and dyspnea. Median survival was shorter for SS-/CXR- patients (6.4 months vs 20.2 and 18.8 months in the other two groups). In multivariate analysis, SS-/CXR-patients had a significantly increased risk of death (hazard ratio 3.0, 95% confidence interval, 1.4 to 6.4, p = 0.004) compared to SS+ patients. This increase in risk was no longer statistically significant when initiation of antituberculous therapy within 8 weeks from the collection date of the first specimen yielding M. tuberculosis was included in the multivariate model. CONCLUSION: Decreased survival was observed in HIV-infectedpatients with pulmonary tuberculosis and with both negative sputum smear and normaL chest X-ray presentation. This may primarily be a resuLt of delayed tuberculosis diagnosis and initiation of antituberculous therapy. The latter delay may also lead to a faster progression of HIV infection in SS-/CXR patients, in whom diagnostic oversight may be common.
Authors: Samuel D Yoo; Adithya Cattamanchi; Saskia Den Boon; William Worodria; Harriet Kisembo; Laurence Huang; J Lucian Davis Journal: Respirology Date: 2011-07 Impact factor: 6.424
Authors: Brian Barnett; Runa H Gokhale; Robert Krysiak; Creto Kanyemba; Tarsizio Chikaonda; Mphatso Bokosi; Cornelius Mukuzunga; Friday Saidi; Sam Phiri; Irving F Hoffman; Mina C Hosseinipour Journal: Trans R Soc Trop Med Hyg Date: 2015-12 Impact factor: 2.184
Authors: H D Geldenhuys; W Kleynhans; N Buckerfield; M Tameris; Y Gonzalez; H Mahomed; G Hussey; W Hanekom; M Hatherill Journal: Eur J Clin Microbiol Infect Dis Date: 2011-07-28 Impact factor: 3.267
Authors: Krishna P Reddy; Mark F Brady; Robert H Gilman; Jorge Coronel; Marcos Navincopa; Eduardo Ticona; Gonzalo Chavez; Eduardo Sánchez; Christian Rojas; Lely Solari; Jorge Valencia; Yvett Pinedo; Carlos Benites; Jon S Friedland; David A J Moore Journal: Clin Infect Dis Date: 2010-04-01 Impact factor: 9.079
Authors: R Mutetwa; C Boehme; M Dimairo; T Bandason; S S Munyati; D Mangwanya; S Mungofa; A E Butterworth; P R Mason; E L Corbett Journal: Int J Tuberc Lung Dis Date: 2009-10 Impact factor: 2.373
Authors: Getachew Aderaye; Haimanot G/Egziabher; Abraham Aseffa; Alemayehu Worku; Lars Lindquist Journal: Ann Thorac Med Date: 2007-10 Impact factor: 2.219